Literature DB >> 26817806

Redox imbalance in peripheral blood of type 1 myotonic dystrophy patients.

Aleksandra Nikolić-Kokić1, Dragan Marinković2, Stojan Perić3, Zorica Stević3, Mihajlo B Spasić1, Duško Blagojević1, Vidosava Rakocˇević-Stojanović3.   

Abstract

OBJECTIVES: The aim of our study was to determine if redox imbalance caused by the activities of antioxidant enzymes existed in erythrocytes of type 1 myotonic dystrophy (DM1) patients.
METHODS: The activities of erythrocyte superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase were measured in 30 DM1 patients and 15 healthy controls (HCs). The obtained values were correlated with the Muscular Impairment Rating Scale (MIRS) score and creatine kinase (CK).
RESULTS: Superoxide dismutase and catalase activities were lower in DM1 patients compared to HCs. A positive correlation was found between disease duration and MIRS score as well as with glutathione reductase activity. In DM1 patients, there were positive correlations between catalase, glutathione peroxidase, and glutathione reductase activities. After sub-dividing DM1 patients according to CK levels, superoxide dismutase activity was still statistically different from HCs. However, catalase activity was significantly lower only in DM1 patients with increased CK. DISCUSSION: Undesirable alterations in antioxidant enzyme activities during DM1 disease progression may result in conditions favoring oxidative stress and changes in metabolism which together could contribute to muscle wasting.

Entities:  

Keywords:  Catalase; Erythrocytes; Glutathione reductase; Glutatione peroxidase; Superoxide dismutase; Type 1 myotonic dystrophy

Mesh:

Substances:

Year:  2016        PMID: 26817806      PMCID: PMC6837567          DOI: 10.1080/13510002.2015.1107311

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  30 in total

1.  Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.

Authors:  C Beauchamp; I Fridovich
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

2.  Adaptive responses of mouse skeletal muscle to contractile activity: The effect of age.

Authors:  A Vasilaki; F McArdle; L M Iwanejko; A McArdle
Journal:  Mech Ageing Dev       Date:  2006-09-22       Impact factor: 5.432

3.  Differential signaling pathways following oxidative stress in mutant myotonin protein kinase cDNA-transfected C2C12 cell lines.

Authors:  F Usuki; N Takahashi; N Sasagawa; S Ishiura
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

Review 4.  Control of reactive oxygen species production in contracting skeletal muscle.

Authors:  Malcolm J Jackson
Journal:  Antioxid Redox Signal       Date:  2011-11-01       Impact factor: 8.401

5.  Preconditioning of skeletal muscle against contraction-induced damage: the role of adaptations to oxidants in mice.

Authors:  F McArdle; S Spiers; H Aldemir; A Vasilaki; A Beaver; L Iwanejko; A McArdle; M J Jackson
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

6.  Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy.

Authors:  Y Ihara; A Mori; T Hayabara; R Namba; K Nobukuni; K Sato; S Miyata; R Edamatsu; J Liu; M Kawai
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

7.  Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle.

Authors:  M B Reid; F A Khawli; M R Moody
Journal:  J Appl Physiol (1985)       Date:  1993-09

8.  Reduction and inactivation of superoxide dismutase by hydrogen peroxide.

Authors:  R C Bray; S A Cockle; E M Fielden; P B Roberts; G Rotilio; L Calabrese
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

Review 9.  Population frequencies of inherited neuromuscular diseases--a world survey.

Authors:  A E Emery
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

10.  Skeletal muscle mitochondria and aging: a review.

Authors:  Courtney M Peterson; Darcy L Johannsen; Eric Ravussin
Journal:  J Aging Res       Date:  2012-07-19
View more
  2 in total

1.  Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1).

Authors:  Eva Alegre-Cortés; Alberto Giménez-Bejarano; Elisabet Uribe-Carretero; Marta Paredes-Barquero; André R A Marques; Mafalda Lopes-da-Silva; Otília V Vieira; Saray Canales-Cortés; Pedro J Camello; Guadalupe Martínez-Chacón; Ana Aiastui; Roberto Fernández-Torrón; Adolfo López de Munain; Patricia Gomez-Suaga; Mireia Niso-Santano; Rosa A González-Polo; José M Fuentes; Sokhna M S Yakhine-Diop
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

2.  Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).

Authors:  Sylvia Nieuwenhuis; Joanna Widomska; Paul Blom; Peter-Bram A C 't Hoen; Baziel G M van Engelen; Jeffrey C Glennon
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.